These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33570858)

  • 1. Positive Fecal Immunochemical Test Strongly Predicts Adenomas in Younger Adults With Fatty Liver and Metabolic Syndrome.
    Yeh JH; Lin CW; Wang WL; Lee CT; Chen JC; Hsu CC; Wang JY
    Clin Transl Gastroenterol; 2021 Feb; 12(2):e00305. PubMed ID: 33570858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fecal immunochemical test cut-off levels on adenoma detection rate: a systematic review and meta-analysis.
    Zarandi-Nowroozi M; Taghiakbari M; Barkun A; Pohl H; Nauche B; Chagnon M; von Renteln D
    Scand J Gastroenterol; 2024 Aug; 59(8):882-892. PubMed ID: 38775234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenoma detection rates in colonoscopies for positive fecal immunochemical tests versus direct screening colonoscopies.
    Wong JCT; Chiu HM; Kim HS; Byeon JS; Matsuda T; Kobayashi N; Wu DC; Ong DE; Sung JJY;
    Gastrointest Endosc; 2019 Mar; 89(3):607-613.e1. PubMed ID: 30452915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining Benchmarks for Adenoma Detection Rate and Adenomas Per Colonoscopy in Patients Undergoing Colonoscopy Due to a Positive Fecal Immunochemical Test.
    Hilsden RJ; Bridges R; Dube C; McGregor SE; Naugler C; Rose SM; Rostom A; Heitman SJ
    Am J Gastroenterol; 2016 Dec; 111(12):1743-1749. PubMed ID: 27725649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenoma Detection Rate in Asymptomatic Patients with Positive Fecal Immunochemical Tests.
    Kligman E; Li W; Eckert GJ; Kahi C
    Dig Dis Sci; 2018 May; 63(5):1167-1172. PubMed ID: 29468377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of Fecal Immunochemical Testing Levels With Pathology Results in a National Colorectal Cancer Screening Program.
    O'Reilly SM; MacNally S; O'Donoghue D; Mooney T; Fitzpatrick P; Mulcahy HE; Cullen G
    Clin Transl Gastroenterol; 2021 Jan; 12(1):e00277. PubMed ID: 33512944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of a higher fecal immunochemistry test cut-off on pathology detected in subsequent rounds of a colorectal screening program.
    Gibson DJ; Mooney T; Mooney J; Mulcahy HE; O'Donoghue D
    Gastrointest Endosc; 2019 Mar; 89(3):518-522. PubMed ID: 30142350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Oral Anticoagulants and Aspirin on Performance of Fecal Immunochemical Tests in Colorectal Cancer Screening.
    Randel KR; Botteri E; Romstad KMK; Frigstad SO; Bretthauer M; Hoff G; de Lange T; Holme Ø
    Gastroenterology; 2019 May; 156(6):1642-1649.e1. PubMed ID: 30689972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic yield and miss rate of EndoRings in an organized colorectal cancer screening program: the SMART (Study Methodology for ADR-Related Technology) trial.
    Hassan C; Senore C; Manes G; Fuccio L; Iacopini F; Ricciardiello L; Anderloni A; Frazzoni L; Ballanti R; de Nucci G; Colussi D; Redaelli D; Lorenzetti R; Devani M; Arena I; Grossi C; Andrei F; Balestrazzi E; Sharma P; Rex DK; Repici A
    Gastrointest Endosc; 2019 Mar; 89(3):583-590.e1. PubMed ID: 30365984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy comparison among high risk factors questionnaire and Asia-Pacific colorectal screening score and their combinations with fecal immunochemical test in screening advanced colorectal tumor].
    Zhu N; Huang YQ; Song YM; Zhang SZ; Zheng S; Yuan Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jul; 25(7):612-620. PubMed ID: 35844124
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors associated with false-positive and false-negative fecal immunochemical test results for colorectal cancer screening.
    Wong MC; Ching JY; Chan VC; Lam TY; Luk AK; Ng SS; Sung JJ
    Gastrointest Endosc; 2015 Mar; 81(3):596-607. PubMed ID: 25293827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fecal immunochemical test in cancer screening - colonoscopy outcome in FIT positives and negatives.
    Ribbing Wilén H; Blom J; Höijer J; Andersson G; Löwbeer C; Hultcrantz R
    Scand J Gastroenterol; 2019 Mar; 54(3):303-310. PubMed ID: 30907196
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictive Modeling of Colonoscopic Findings in a Fecal Immunochemical Test-Based Colorectal Cancer Screening Program.
    Law J; Rajan A; Trieu H; Azizian J; Berry R; Beaven SW; Tabibian JH
    Dig Dis Sci; 2022 Jul; 67(7):2842-2848. PubMed ID: 34350518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex is a stronger predictor of colorectal adenoma and advanced adenoma than fecal occult blood test.
    Ferlitsch M; Heinze G; Salzl P; Britto-Arias M; Waldmann E; Reinhart K; Bannert C; Fasching E; Knoflach P; Weiss W; Trauner M; Ferlitsch A
    Med Oncol; 2014 Sep; 31(9):151. PubMed ID: 25115743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are hemoglobin levels really lower in faecal immunochemical test positive patients with colorectal cancer?
    Ng JY; Tan IJ; Tan KK
    Surgeon; 2018 Feb; 16(1):36-39. PubMed ID: 28108269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
    Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
    BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal Immunologic Test Results and Diagnostic Colonoscopy in a Mexican Population at Average Risk for Colorectal Cancer.
    Manzano-Robleda MDC; Espinosa-Tamez P; Potter MB; Lajous M; Van Loon K; Zhang L; Jimenez-Peña A; Sánchez Del Monte J; Mohar A; Hernández-Guerrero A
    Cancer Prev Res (Phila); 2020 Nov; 13(11):959-966. PubMed ID: 32655008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fecal immunochemical testing results and characteristics of colonic lesions.
    van Doorn SC; Stegeman I; Stroobants AK; Mundt MW; de Wijkerslooth TR; Fockens P; Kuipers EJ; Bossuyt PM; Dekker E
    Endoscopy; 2015 Nov; 47(11):1011-7. PubMed ID: 26126163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal haemoglobin concentration influences risk prediction of interval cancers resulting from inadequate colonoscopy quality: analysis of the Taiwanese Nationwide Colorectal Cancer Screening Program.
    Chiu SY; Chuang SL; Chen SL; Yen AM; Fann JC; Chang DC; Lee YC; Wu MS; Chou CK; Hsu WF; Chiou ST; Chiu HM
    Gut; 2017 Feb; 66(2):293-300. PubMed ID: 26515543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.